Japanese encephalitis vaccine in travelers

References

• Japanese encephalitis. Inactivated Japanese encephalitis virus vaccine. Wkly Epidemiol. Rec.69(16), 113–118 (1994).
   PubMedGoogle Scholar
• Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly Rep.42(RR-1), 1–15 (1993).
   PubMedGoogle Scholar
• Igarashi A. Epidemiology and control of Japanese encephalitis. World Health Stat. Q.45(2–3), 299–305 (1992).
   PubMedGoogle Scholar
• Umenai T, Krzysko R, Bektimirov A, Assaad A. Japanese encephalitis: current worldwide status. Bull. World Health Organ.63, 623–631 (1985).
   Web of Science ®Google Scholar
• Wong SC, Ooi MH, Abdullah AR et al. A decade of Japanese encephalitis surveillance in Sarawak, Malaysia: 1997–2006. Trop. Med. Int. Health13, 52–55 (2008).
   PubMed Web of Science ®Google Scholar
• Kari K, Liu W, Gautama K et al. A hospital-based surveillance for Japanese encephalitis in Bali, Indonesia. BMC Med.4, 8 (2006).
   PubMed Web of Science ®Google Scholar
• Bista MB, Shrestha JM. Epidemiological situation of Japanese encephalitis in Nepal. J. Nepal Med. Assoc.44(158), 51–56 (2005).
   PubMedGoogle Scholar
• Lam K, Tsang OT, Yung RW, Lau KK. Japanese encephalitis in Hong Kong. Hong Kong Med. J.11, 182–188 (2005).
   PubMedGoogle Scholar
• Monath T. Japanese encephalitis – a plague of the orient. New Engl. J. Med.319, 641–643 (1988).
   PubMedGoogle Scholar
• Okuno T. An epidemiological review of Japanese encephalitis. World Health Stat. Q.3, 120–131 (1978).
   Google Scholar
• Thogcharoen P. Japanese encephalitis virus encephalitis: an overview. Southeast Asian J. Trop. Med. Public Health20, 559–573 (1989).
   PubMedGoogle Scholar
• Rosen L. The natural history of Japanese encephalitis virus. Ann. Rev. Microbiol.40, 395–414 (1986).
   PubMed Web of Science ®Google Scholar
• Sucharit S, Surathin K, Shrestha S. Vectors of Japanese encephalitis virus (JEV): species complexes of the vectors. Southeast Asian J. Trop. Med. Public Health20, 611–621 (1989).
   PubMedGoogle Scholar
• Hoke C, Nisalak A, Sangawhipa N et al. Protection against Japanese encephalitis by inactivated vaccines. N. Engl. J. Med.319, 608–614 (1988).
   PubMed Web of Science ®Google Scholar
• Simpson TW, Meiklejohn G. Sequelae of Japanese B encephalitis. Am. J. Trop. Med.27, 727–731 (1947).
   PubMed Web of Science ®Google Scholar
• Solomon T, Vaughn DW. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr. Top. Microbiol. Immunol.267, 171–194 (2002).
   PubMed Web of Science ®Google Scholar
• Solomon T. Control of Japanese encephalitis – within our grasp? N. Engl. J. Med.355(9), 869–871 (2006).
   PubMed Web of Science ®Google Scholar
• Macdonald W, Tink A, Ouvrier R. Japanese encephalitis after a two-week holiday in Bali. Med. J. Aust.150, 334–337 (1989).
   PubMed Web of Science ®Google Scholar
• Wittesjö B, Eitrem R, Niklasson B, Vene S, Mangiafico J. Japanese encephalitis after a 10-day holiday in Bali. Lancet345, 856 (1995).
   PubMed Web of Science ®Google Scholar
• Tsarev SA, Sanders ML, Vaughn DW et al. Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus. Vaccine18(Suppl. 2), 36–43 (2000).
   PubMed Web of Science ®Google Scholar
• Oya A. Japanese encephalitis vaccine. Acta Pediatr. Jpn30, 175–184 (1988).
   PubMedGoogle Scholar
• Rojanasuphot S, Charoensuk O, Kityprayura D. A field trial of Japanese encephalitis virus vaccine produced in Thailand. Southeast Asian J. Trop. Med. Public Health20, 653–654 (1989).
   PubMedGoogle Scholar
• Rao Bhau L, Singh F, Gowal D. Safety and efficacy of Japanese encephalitis vaccine produced in India. Indian J. Med. Res.88, 301–307 (1988).
   PubMedGoogle Scholar
• Shepard D, Halstead S. Dengue. In: Disease Control Priorities in Developing Countries. Jamison DT, Mosley WH, Measham AR, Bobadilla JL (Eds). Oxford University Press, Inc., NY, USA303–330 (1993).
   Google Scholar
• Tsai T, Yu Y. Japanese encephalitis vaccines. In: Vaccines (2nd Edition). Plotkin S, Mortimer EJ (Eds). WB Saunders, PA, USA 671–713 (1995).
   Google Scholar
• Luo D, Yin H, Xili L, Song J, Wang Z. The efficacy of Japanese encephalitis vaccine in Henan, China: a case–control study. Southeast Asian J. Trop. Med. Public Health25(4), 643–646 (1994).
   PubMedGoogle Scholar
• Hennessy S, Zehngle L, Tsai T et al. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA 14–14–2), a case control study. Lancet347, 1583–1586 (1996).
   PubMed Web of Science ®Google Scholar
• Steinhoff M. Japanese encephalitis: a Chinese solution? Lancet347, 1570–1571 (1996).
   PubMed Web of Science ®Google Scholar
• Poland J, Cropp C, Craven R, Monath T. Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants. J. Infect. Dis.161, 878–882 (1990).
   PubMed Web of Science ®Google Scholar
• Sanchez J, Hoke C, McCowan J. Further experience with Japanese encephalitis vaccine. Lancet335, 972–973 (1990).
   PubMed Web of Science ®Google Scholar
• Japanese encephalitis vaccine and adverse effects among travelers. Can. Dis. Wkly Rep.17, 173–177 (1991).
   PubMedGoogle Scholar
• Berg SW, Mitchell BS, Hanson RK et al. Systemic reactions in U.S. Marine Corps personnel who received Japanese encephalitis vaccine. Clin. Infect. Dis.24, 265–266 (1997).
   PubMed Web of Science ®Google Scholar
• Ohtaki E, Murakami Y, Komori H, Yamashita Y, Matsuishi T. Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination. Pediatr. Neurol.8(2), 137–139 (1992).
   PubMed Web of Science ®Google Scholar
• Andersen MM, Ronne T. Side-effects with Japanese encephalitis vaccine [letter]. Lancet337(8748), 1044 (1991).
   PubMed Web of Science ®Google Scholar
• Ruff TA, Eisen D, Fuller A, Kass R. Adverse reactions to Japanese encephalitis vaccine [letter]. Lancet338(8771), 881–882 (1991).
   PubMed Web of Science ®Google Scholar
• Nothdurft HD, Jelinek T, Marschang A, Maiwald H, Kapaun A, Löscher T. Adverse reactions to Japanese encephalitis vaccine in German travelers. J. Infect.32, 119–122 (1996).
   PubMed Web of Science ®Google Scholar
• Tsai TF. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI Meeting, Bangkok, Thailand, 13–15 October 1998. Vaccine18(Suppl. 2), 1–25 (2000).
   PubMed Web of Science ®Google Scholar
• Liu ZL, Hennessy S, Strom BL et al. Short-term safety of live attenuated Japanese encephalitis vaccine (SA14–14–2), results of a randomized trial with 26,239 subjects. J. Infect. Dis.176, 1366–1369 (1997).
   PubMed Web of Science ®Google Scholar
• Tauber E, Dewasthaly S. Japanese encephalitis vaccines – needs, flaws and achievements. Biol. Chem. (2008) (Epub ahead of print).
   PubMedGoogle Scholar
• Tauber E, Kollaritsch H, Korinek M et al. Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, Phase III, randomised controlled trial. Lancet370, 1847–1853 (2007).
   PubMed Web of Science ®Google Scholar
• Guirakhoo F, Zhang ZX, Chambers TJ et al. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis. Virology257, 363–372 (1999).
   PubMed Web of Science ®Google Scholar
• Monath TP, Soike K, Levenbook I et al. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14–14–2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates. Vaccine17, 1869–1882 (1999).
   PubMed Web of Science ®Google Scholar
• Monath TP, McCarthy K, Bedford P et al. Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections. Vaccine20, 1004–1018 (2002).
   PubMed Web of Science ®Google Scholar
• Monath TP, Guirakhoo F, Nichols R et al. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE), Phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. J. Infect. Dis.188, 1213–1230 (2003).
   PubMed Web of Science ®Google Scholar